Andrew J. Fromkin serves as Executive at Tobira Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew J. Fromkin has executed 14 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2025 involved selling 2,898 shares valued at $69.4K.
Andrew J. Fromkin currently holds 85,852 shares of Tobira Therapeutics, Inc. (TBRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Fromkin has been a net seller of TBRA stock. They have purchased $43.5K and sold $1.0M worth of shares.
Andrew J. Fromkin's most recent insider trade was on Dec 1, 2025, when they sold 2,898 shares at $23.95 per share.
Get notified when new Form 4 filings are submitted
| $23.14 |
| Discretionary |
| Apr 2, 2024 | IMVT | $0 | Award | 11,255 | $N/A | Discretionary |
| Dec 1, 2023 | IMVT | $144.7K | Sale | 3,636 | $39.81 | Planned |
| Dec 1, 2023 | IMVT | $193.1K | Sale | 4,773 | $40.46 | Planned |
| Dec 1, 2023 | IMVT | $152.8K | Sale | 3,941 | $38.78 | Planned |
| Apr 12, 2023 | IMVT | $0 | Award | 12,523 | $N/A | Discretionary |
| Aug 17, 2022 | IMVT | $0 | Award | 21,059 | $N/A | Discretionary |
| Jan 10, 2022 | IMVT | $0 | Award | 21,726 | $N/A | Discretionary |
| Aug 10, 2021 | IMVT | $43.5K | Purchase | 5,500 | $7.90 | Discretionary |
| Mar 19, 2021 | IMVT | $0 | Award | 15,500 | $N/A | Discretionary |
| May 15, 2020 | IMVT | $0 | Award | 24,700 | $N/A | Discretionary |
| Nov 1, 2016 | TBRA | $0 | Tender | 11 | $N/A | Discretionary |
| Nov 1, 2016 | TBRA | $0 | Tender | 5 | $N/A | Discretionary |